Scientific blog article: A research summary on oncolytic virus driven combination immunotherapy in disease models from Bio X Cell

by | May 7, 2024 | Cancer, Immunology, in vivo Studies, Neurology

ARTICLE FROM BIO X CELL

A publication summary describing oncolytic virus driven combination immunotherapy in disease models

Bio X Cell has recently published a scientific blog article featuring a journal publication that highlights a research study conducted by team of investigators led by John Cameron Bell, describing a novel combination of T-cell based immunotherapy and oncolytic viruses in disease models.

Read more about the publication summary, have a glance at some featured in vivo antibodies for your next research project from Bio X Cell, as well as explore additional related Bio X Cell antibodies for cancer and immunology research.

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

ABOUT BIO X CELL

Antibodies For In Vivo Research

Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.

 

    • Exceptional Purity
    • Pathogen Free
    • Ultra-low Endotoxin Level
    • Advanced Binding Validation
    • Low Protein Aggregation
    • Marching Isotype Control Antibodies

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

Reference: 

  1. Bio X Cell, ‘Oncolytic virus driven combination immunotherapy shows promise in colorectal cancer’ Available at https://bioxcell.com/oncolytic-virus-driven-combination/

Learn more on our comprehensive in-vivo research reagents today.

Contact us
Share This